This report examines the biotech industry's corporate lobby power and its access to one of the key EU institutions, the European Commission. It focuses on one of the key biotech lobby groups - EuropaBio - and recent examples of the cosy relationship between the companies who stand to make considerable profits from agricultural biotechnology, and policy makers at the European Commission.
Nuclear power plant operators have a ridiculously small liability insurance for compensating damage when an accidents occurs. This position paper exposes the scale of the gap between the insured sum and the huge financial risk of nuclear accidents.
It also introduces an alternative system for insuring nuclear power plants which is currently being discussed between academics and regulators. This system might provide at least more financial security for people living in the area around nuclear power plants.